Intravenous Exenatide (Byetta) Versus Insulin for Perioperative Glycemic Control in Cardiac Surgery: the Open-labeled Randomized Phase II/III ExStress Study
Phase of Trial: Phase II/III
Latest Information Update: 10 Oct 2017
Price : $35 *
At a glance
- Drugs Exenatide (Primary) ; Insulin lispro
- Indications Hyperglycaemia
- Focus Therapeutic Use
- Acronyms ExSTRESS
- 05 Oct 2017 Status changed from recruiting to completed.
- 15 Jun 2016 Status changed from active, no longer recruiting to recruiting.
- 30 Mar 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.